SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007568
Filing Date
2021-05-20
Accepted
2021-05-20 07:00:39
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20210331x10q.htm   iXBRL 10-Q 1566306
2 EX-31.1 rphm-20210331xex31d1.htm EX-31.1 12157
3 EX-31.2 rphm-20210331xex31d2.htm EX-31.2 12237
4 EX-32.1 rphm-20210331xex32d1.htm EX-32.1 7274
5 EX-32.2 rphm-20210331xex32d2.htm EX-32.2 6168
6 GRAPHIC rphm-20210331x10q004.jpg GRAPHIC 5743
  Complete submission text file 0001558370-21-007568.txt   5018367

Data Files

Seq Description Document Type Size
7 EX-101.SCH rphm-20210331.xsd EX-101.SCH 36757
8 EX-101.CAL rphm-20210331_cal.xml EX-101.CAL 26769
9 EX-101.DEF rphm-20210331_def.xml EX-101.DEF 133601
10 EX-101.LAB rphm-20210331_lab.xml EX-101.LAB 334303
11 EX-101.PRE rphm-20210331_pre.xml EX-101.PRE 248241
12 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20210331x10q_htm.xml XML 618349
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 21942336
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences